MARIA RAMIREZ: Open Payments
NPI 1952755027 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 77 payments from 19 companies in 2025. Trend: 2023 $1,245 · 2024 $1,863 · 2025 $2,075
Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $334 |
| Daiichi Sankyo Inc. | 8 | $195 |
| SOBI, INC | 8 | $193 |
| Merck Sharp & Dohme LLC | 6 | $161 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| Novartis Pharmaceuticals Corporation | 5 | $135 |
| PharmaEssentia USA Corporation | 6 | $130 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| GENZYME CORPORATION | 5 | $113 |
| Pharmacosmos Therapeutics Inc. | 4 | $102 |
Products named: Jakafi, ENHERTU, INJECTAFER, Doptelet, BESREMI, Fabhalta, MONOFERRIC, AYVAKIT.
Industry payments across FL — which companies pay providers there.
